NEW YORK, NY--(Marketwire - February 10, 2009) - Pink OTC Markets Inc., the leading electronic
inter-dealer quotation system, trading technology and financial information
provider for over-the-counter (OTC) securities, today announced that
Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC), an Australian
biotechnology company focused on oral immunotherapeutic products, has
chosen to list its American Depositary Receipts (ADRs) on International
OTCQX. Immuron's ADRs began trading today on the OTC market's prestigious
tier, International PrimeQX. Investors can find current disclosure and
financial information for the company on www.otcqx.com and
"As an OTCQX-listed company, Immuron distinguishes itself from the
thousands of other companies traded over-the-counter and is associated with
many of the most prestigious companies in our marketplace," said R.
Cromwell Coulson, Chairman and CEO of Pink OTC Markets. "We welcome them
to the International OTCQX market tier."
The Bank of New York Mellon will serve as Immuron's Principal American
Liaison ("PAL") on the International OTCQX, responsible for providing
guidance on listing requirements.
Immuron's ADRs will trade in the United States on International OTCQX under
the ticker "IMROY" where each ADR will represent twenty ordinary shares.
Immuron's shares are also listed on the Australian Securities Exchange
(ASX). The company's headquarters are in Melbourne, Australia.
Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC) is an Australian
biotechnology company with proprietary and proven commercial biotechnology
for producing oral immunotherapeutic products. Their current commercial
products and emerging research pipeline include products that contain
antigen targeted antibodies and other proteins, to address a range
gastrointestinal, infectious and immune-mediated diseases. Product pipeline
includes solutions addressing Flu, HIV, Cancer related Mucositis, Diabetes
and Metabolic Syndrome, and e.coli. For more about Immuron visit
For Investor relations inquiries, contact Dr. Oren Fuerst: email@example.com
About International OTCQX
International OTCQX provides a gateway to U.S. securities markets for
international companies that are listed on a qualified non-U.S. exchange
and provide ongoing disclosure in English to U.S. investors. More
importantly, International OTCQX distinguishes the reputable international
issuers from the 8,000 over-the-counter (OTC) securities traded in the U.S.
Only leading companies that have substantial operating businesses and
provide credible disclosure to the public are eligible for inclusion on the
premium-tier International OTCQX, which commenced trading on March 5, 2007.
For more about International OTCQX, visit www.otcqx.com.
About Pink OTC Markets Inc.
Pink OTC Markets Inc. provides the leading inter-dealer electronic
quotation and trading system in the over-the-counter (OTC) securities
market. We create innovative technology and data solutions to efficiently
connect market participants, improve price discovery, increase issuer
disclosure, and better inform investors. Pink OTC Markets operates the
third largest U.S. equity trading venue which includes both the elite OTCQX
market tiers for strong OTC-traded companies that can satisfy financial and
disclosure listing standards and Pink Sheets for all other OTC quoted
Over 230 financial service firms, including the ten largest U.S. investment
banks, actively make markets in OTCQX and Pink Sheets quoted securities and
in 2007 these firms traded over $160 billion of OTCQX and Pink Sheets
securities. Pink OTC Markets offers widespread access to all U.S.
broker-dealers, enabling investors to seamlessly trade these securities
through their institutional, online, or full service brokers.
Pink OTC Markets is headquartered in New York City.
To learn more about how Pink OTC Markets' products and services make OTC
markets more transparent, informed, and efficient, please visit our
websites at www.pinkotc.com, www.pinksheets.com and www.otcqx.com or
contact us at firstname.lastname@example.org.